Correlation Between Inhibrx and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Karyopharm Therapeutics, you can compare the effects of market volatilities on Inhibrx and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Karyopharm Therapeutics.
Diversification Opportunities for Inhibrx and Karyopharm Therapeutics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inhibrx and Karyopharm is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Karyopharm Therapeutics
Given the investment horizon of 90 days Inhibrx is expected to generate 0.48 times more return on investment than Karyopharm Therapeutics. However, Inhibrx is 2.08 times less risky than Karyopharm Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Karyopharm Therapeutics is currently generating about -0.16 per unit of risk. If you would invest 1,355 in Inhibrx on December 1, 2024 and sell it today you would lose (30.00) from holding Inhibrx or give up 2.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Karyopharm Therapeutics
Performance |
| Timeline |
| Inhibrx |
| Karyopharm Therapeutics |
Inhibrx and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Karyopharm Therapeutics
The main advantage of trading using opposite Inhibrx and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |